| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |